Tower Research Capital LLC (TRC) - BONE BIOLOGICS CORP ownership

BONE BIOLOGICS CORP's ticker is and the CUSIP is 098070303. A total of 4 filers reported holding BONE BIOLOGICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BONE BIOLOGICS CORP
ValueSharesWeighting
Q1 2023$20.0%8,3110.0%0.00%
Q4 2022$2
-100.0%
8,311
+5.5%
0.00%
Q3 2022$8,000
-11.1%
7,877
+27.8%
0.00%
Q2 2022$9,0006,1650.00%
Other shareholders
BONE BIOLOGICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 13,464$37,0000.00%
UBS Group AG 85$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Citadel Advisors 10,741$30,0000.00%
VANGUARD GROUP INC 33,461$93,0000.00%
View complete list of BONE BIOLOGICS CORP shareholders